Medical bill for lung cancer patients goes down
Published: 2010-02-04 06:56:00
Updated: 2010-02-04 06:56:00
Korea’s National Health Insurance has expanded its coverage to Eli Lilly’s chemotherapy drug Alimta (pemetrexed) as the first line drug for locally advanced or metastatic, nonsquamous, non-small cell lung cancer, according to Lilly Korea.
Non-small cell lung cancer (NSCLC) is the most common t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
